WH Oertel

4.2k total citations
52 papers, 3.6k citations indexed

About

WH Oertel is a scholar working on Cellular and Molecular Neuroscience, Neurology and Molecular Biology. According to data from OpenAlex, WH Oertel has authored 52 papers receiving a total of 3.6k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Cellular and Molecular Neuroscience, 18 papers in Neurology and 15 papers in Molecular Biology. Recurrent topics in WH Oertel's work include Neuroscience and Neuropharmacology Research (13 papers), Parkinson's Disease Mechanisms and Treatments (12 papers) and Receptor Mechanisms and Signaling (7 papers). WH Oertel is often cited by papers focused on Neuroscience and Neuropharmacology Research (13 papers), Parkinson's Disease Mechanisms and Treatments (12 papers) and Receptor Mechanisms and Signaling (7 papers). WH Oertel collaborates with scholars based in Germany, United States and France. WH Oertel's co-authors include Marcel Tappaz, D.E. Schmechel, I J Kopin, Enrico Mugnaini, A.A.J. Verhofstad, Tomas Hökfelt, Menek Goldstein, T. Melander, A. Claudio Cuello and Åke Rökaeus and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Journal of Neuroscience.

In The Last Decade

WH Oertel

51 papers receiving 3.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
WH Oertel Germany 25 2.3k 1.2k 717 513 392 52 3.6k
Tomás A. Reader Canada 34 2.4k 1.0× 1.2k 1.0× 399 0.6× 484 0.9× 289 0.7× 111 3.4k
Hitoo Nishino Japan 38 1.9k 0.8× 1.2k 1.0× 542 0.8× 821 1.6× 538 1.4× 149 4.1k
A. Weindl Germany 30 1.5k 0.6× 855 0.7× 647 0.9× 308 0.6× 346 0.9× 77 3.2k
Jean‐Pierre Hornung Switzerland 33 2.0k 0.9× 1.1k 0.9× 241 0.3× 961 1.9× 289 0.7× 61 3.6k
Heinz Steiner United States 34 3.0k 1.3× 1.4k 1.2× 624 0.9× 873 1.7× 321 0.8× 79 4.0k
Ronald G. Wiley United States 33 2.4k 1.0× 1.5k 1.2× 296 0.4× 1.1k 2.1× 885 2.3× 68 4.0k
Laurent Vinay France 34 1.7k 0.7× 936 0.8× 247 0.3× 579 1.1× 464 1.2× 68 3.3k
Jean‐Jacques Soghomonian United States 33 2.4k 1.0× 1.0k 0.8× 928 1.3× 748 1.5× 210 0.5× 60 3.5k
Monique Touret France 24 1.5k 0.6× 632 0.5× 347 0.5× 882 1.7× 486 1.2× 48 2.9k
Hideho Higashi Japan 33 2.3k 1.0× 1.8k 1.5× 240 0.3× 414 0.8× 630 1.6× 93 3.3k

Countries citing papers authored by WH Oertel

Since Specialization
Citations

This map shows the geographic impact of WH Oertel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by WH Oertel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites WH Oertel more than expected).

Fields of papers citing papers by WH Oertel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by WH Oertel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by WH Oertel. The network helps show where WH Oertel may publish in the future.

Co-authorship network of co-authors of WH Oertel

This figure shows the co-authorship network connecting the top 25 collaborators of WH Oertel. A scholar is included among the top collaborators of WH Oertel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with WH Oertel. WH Oertel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Diener, HC, et al.. (2012). Leitlinien für Diagnostik und Therapie in der Neurologie. 5. vollständig überarbeitete Auflage. Thieme eBooks. 1 indexed citations
3.
Belke, Marcus, K Hattemer, Boris Keil, et al.. (2010). Diffusion Tensor Imaging (DTI) in idiopathic REM sleep behaviour disorder (iRBD). Klinische Neurophysiologie. 41(1). 3 indexed citations
4.
Balzer‐Geldsetzer, Monika, et al.. (2009). PND38 COSTS AND HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH GILLES DE LA TOURETTE'S SYNDROME. Value in Health. 12(7). A372–A373. 1 indexed citations
5.
6.
Kupsch, Andreas, J. Sautter, Mario E. Götz, et al.. (2001). Monoamine oxidase-inhibition and MPTP-induced neurotoxicity in the non-human primate: comparison of rasagiline (TVP 1012) with selegiline. Journal of Neural Transmission. 108(8). 985–1009. 118 indexed citations
7.
Oertel, WH, et al.. (2000). Restless-Legs-Syndrom - Die vergessene Krankheit.. Max Planck Institute for Plasma Physics. 44. 1 indexed citations
8.
Collado-Seidel, Victor, Ralf Kohnen, W. Samtleben, et al.. (1998). Clinical and biochemical findings in uremic patients with and without restless legs syndrome. American Journal of Kidney Diseases. 31(2). 324–328. 132 indexed citations
9.
Künig, G., Oliver Pogarell, & WH Oertel. (1998). Facial pain in a case of cranial dystonia: a case report. Cephalalgia. 18(10). 709–711. 5 indexed citations
10.
Poewe, Werner, Günther Deuschl, Jörg Wissel, et al.. (1998). What is the optimal dose of botulinum toxin A in the treatment of cervical dystonia? Results of a double blind, placebo controlled, dose ranging study using Dysport . Journal of Neurology Neurosurgery & Psychiatry. 64(1). 13–17. 167 indexed citations
11.
Arnold, G., et al.. (1997). Domperidone is superior to ondansetron in acute apomorphine challenge in previously untreated parkinsonian patients — A double blind study. Parkinsonism & Related Disorders. 3(4). 191–193. 11 indexed citations
12.
Dodel, Richard, R Köhne-Volland, Thomas D. Szucs, et al.. (1996). [Costs of drug treatment of neurologic diseases: Parkinson disease, dystonia, epilepsy].. PubMed. 91(7). 479–85. 7 indexed citations
13.
Straube, Andreas, et al.. (1993). Time course of distant effects of local injections of botulinum toxin. Movement Disorders. 8(1). 33–37. 100 indexed citations
14.
Gasser, Thomas, Johannes Schwarz, G. Arnold, C. Trenkwalder, & WH Oertel. (1992). Apomorphine Test for Dopaminergic Responsiveness in Patients With Previously Untreated Parkinson's Disease. Archives of Neurology. 49(11). 1131–1134. 59 indexed citations
15.
Massari, V. John, J. Chan, Bibie M. Chronwall, et al.. (1988). Neuropeptide Y in the rat nucleus accumbens: Ultrastructural localization in aspiny neurons receiving synaptic input from GABAergic terminals. Journal of Neuroscience Research. 19(2). 171–186. 38 indexed citations
16.
Melander, T., Tomas Hökfelt, Åke Rökaeus, et al.. (1986). Coexistence of galanin-like immunoreactivity with catecholamines, 5- hydroxytryptamine, GABA and neuropeptides in the rat CNS. Journal of Neuroscience. 6(12). 3640–3654. 460 indexed citations
17.
18.
19.
Oertel, WH, D.E. Schmechel, Virginia K. Weise, et al.. (1981). Comparison of cysteine sulphinic acid decar☐ylase isoenzymes and glutamic acid decar☐ylase in rat liver and brain. Neuroscience. 6(12). 2701–2714. 76 indexed citations
20.
Oertel, WH, et al.. (1980). Production of an antiserum to rat brain glutamate (GAD)/cysteine sulfinate (CSD) decarboxylase. Brain Research Bulletin. 5. 713–719. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tomás A. Reader Breakdown of academic impact, for papers by Hitoo Nishino Breakdown of academic impact, for papers by A. Weindl Breakdown of academic impact, for papers by Jean‐Pierre Hornung Breakdown of academic impact, for papers by Heinz Steiner Breakdown of academic impact, for papers by Ronald G. Wiley Breakdown of academic impact, for papers by Laurent Vinay Breakdown of academic impact, for papers by Jean‐Jacques Soghomonian Breakdown of academic impact, for papers by Monique Touret Breakdown of academic impact, for papers by Hideho Higashi
Rankless by CCL
2026